Cmtm4 Deficiency Inhibits Helicobacter pylori ‐Induced Gastric Carcinogenesis
Pathology International · 2025
DOI: 10.1111/pin.70020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology International, 2025. Verfasst von Yanfei Lang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter Infections, Carcinogenesis, MARVEL Domain-Containing Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: This study was funded by the National Natural Science Foundation of China (grant numbers 81870386 and 82371771) and the National Key Research and Development P….
Abstract (Originalsprache)
Helicobacter pylori is the main pathogenic factor in gastric cancer (GC), and the interleukin (IL)‐17‐mediated inflammatory response plays a crucial role in both H. pylori infection and gastric carcinogenesis. CMTM4, a subunit of the IL‐17 receptor (IL‐17R), has been implicated in immune responses, but its role in GC development remains unclear. In this study, we investigate the role of CMTM4 during H. pylori ‐induced gastric carcinogenesis using Cmtm4 knockout (KO) mice. Our findings indicated that Cmtm4 deficiency inhibited GC development and pseudopyloric metaplasia, while reducing DNA damage in the gastric mucosa. Mechanistically, Cmtm4 deletion downregulated the IL‐17 signaling pathway in GC. Specifically, it suppressed the expression of IL‐17 receptor RC (IL‐17RC) and its downstream signaling molecules, resulting in the inhibition of nuclear factor‐κ B (NF‐κB) activation and a decrease in NADPH oxidase‐1 (NOX1) levels. These results suggest that Cmtm4 deletion suppresses H. pylori ‐induced gastric carcinogenesis and precancerous lesion formation, potentially through the regulation of IL‐17RC/NF‐κB/NOX1 signaling, which may represent a new target for the early prevention of GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
- Beijing Key Laboratory for Helicobacter Pylori Infection and Upper Gastrointestinal Diseases (BZ0317), Beijing, China.
- Central Laboratory of Shengli Oilfield Central Hospital, Dongying Key Laboratory of Cell Biology, Dongying, China.
- Department of Gastroenterology Pathology Laboratory, Peking University Third Hospital, Beijing, China.
Förderung
- This study was funded by the National Natural Science Foundation of China (grant numbers 81870386 and 82371771) and the National Key Research and Development P…
Zitieren
APA
Lang, Y., Han, X., Liu, X., Ning, J., Hao, X., Zhang, H., Zhang, J., Zhai, K., Zhang, J., Fu, W., & Ding, S. (2025). Cmtm4 Deficiency Inhibits Helicobacter pylori ‐Induced Gastric Carcinogenesis. Pathology International. https://doi.org/10.1111/pin.70020
Vancouver
Lang Y, Han X, Liu X, Ning J, Hao X, Zhang H, et al. Cmtm4 Deficiency Inhibits Helicobacter pylori ‐Induced Gastric Carcinogenesis. Pathology International. 2025. doi:10.1111/pin.70020
BibTeX
@article{Lang2025,
author = {Lang, Yanfei and Han, Xiurui and Liu, Xin and Ning, Jing and Hao, Xinyu and Zhang, Hejun and Zhang, Jing and Zhai, Kangle and Zhang, Jing and Fu, Weiwei and Ding, Shigang},
title = {Cmtm4 Deficiency Inhibits Helicobacter pylori ‐Induced Gastric Carcinogenesis},
journal = {Pathology International},
year = {2025},
doi = {10.1111/pin.70020}
}
EUVIMED